Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
395.00
+1.00 (0.25%)
Sep 8, 2026, 11:49 AM CST

Sunmax Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
811.53725.75679.41625.71533.83245.64
Depreciation & Amortization
113.21102.3199.2172.8358.1555.76
Loss (Gain) From Sale of Assets
0.580.430.490.13-0.462.1
Provision & Write-off of Bad Debts
-----0.390.24
Other Operating Activities
19.2215.72-21.5917.9642.5218.34
Change in Accounts Receivable
-0.79-0.340.47-0.233.341.81
Change in Inventory
-32.74.7-63.69-19.88-19.05-29.41
Change in Accounts Payable
1.82-11.0211.35-7.619.463.58
Change in Unearned Revenue
12.35-51.8-128.72142.48-62.8611.01
Change in Other Net Operating Assets
34.0640.18-15.9117.1780.03-65.8
Operating Cash Flow
959.28825.92561.04848.56644.57243.28
Operating Cash Flow Growth
28.98%47.21%-33.88%31.65%164.95%-37.13%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-88.81-59.61-31.97-107.66-154.58-253.02
Sale of Property, Plant & Equipment
---0.420.513.1
Cash Acquisitions
---7.2---
Sale (Purchase) of Intangibles
-8.73-8.73-5.03-2.73-0.59-2.4
Sale (Purchase) of Real Estate
----0.96--
Investment in Securities
-362.74-16124.96125-136.4339.68
Other Investing Activities
-6.96-10.62-2.71-30.1-85.53-72.53
Investing Cash Flow
-467.23-239.96-21.94-16.04-376.62-285.17

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--30.08-29.65-22.97-39.16-24.39
Lease Payments
-31.72-30.08-29.65-22.97-39.16-24.39
Net Debt Issued (Repaid)
-31.72-30.08-29.65-22.97-39.16-24.39
Common Dividends Paid
-1,291-631.77-599.09-517.4-239.64-108.93
Other Financing Activities
2.13-1.282.64-9.43-2.411.35
Financing Cash Flow
-1,320-663.13-626.11-549.8-281.21-131.97

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
41.4313.297.79-17.330.01-2.18
Net Cash Flow
-786.89-63.88-79.23265.39-13.25-176.03

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
870.47766.31529.07740.9489.99-9.74
Free Cash Flow Growth
19.97%44.84%-28.59%51.21%--
Free Cash Flow Margin
39.66%37.82%29.10%43.87%35.00%-0.94%
Free Cash Flow Per Share
15.9614.059.7013.598.98-0.18
Levered Free Cash Flow
106.41663.18400.4612.07412.527.73
Unlevered Free Cash Flow
109.05666.12404.12613.91413.369.48
Free Cash Flow After Leases
838.75736.23499.42717.93450.84-34.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.424.885.952.941.352.81
Cash Income Tax Paid
289.52284.39289.64259.68199.7492.59
Change in Working Capital
14.74-18.28-196.49131.9310.91-78.8